Filtros : "Kobayashi, Tsuneo" Limpar

Filtros



Refine with date range


  • Source: British Journal of Pharmacology. Unidade: FMRP

    Subjects: ENDOTÉLIO VASCULAR, ADENOSINA, HIPERTENSÃO, DIABETES MELLITUS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MATSUMOTO, Takayuki et al. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. British Journal of Pharmacology, v. 172, n. 16, p. 3980-4001, 2015Tradução . . Disponível em: https://doi.org/10.1111/bph.13205. Acesso em: 29 set. 2024.
    • APA

      Matsumoto, T., Goulopoulou, S., Taguchi, K., Tostes, R. de C. A., & Kobayashi, T. (2015). Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. British Journal of Pharmacology, 172( 16), 3980-4001. doi:10.1111/bph.13205
    • NLM

      Matsumoto T, Goulopoulou S, Taguchi K, Tostes R de CA, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes [Internet]. British Journal of Pharmacology. 2015 ; 172( 16): 3980-4001.[citado 2024 set. 29 ] Available from: https://doi.org/10.1111/bph.13205
    • Vancouver

      Matsumoto T, Goulopoulou S, Taguchi K, Tostes R de CA, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes [Internet]. British Journal of Pharmacology. 2015 ; 172( 16): 3980-4001.[citado 2024 set. 29 ] Available from: https://doi.org/10.1111/bph.13205
  • Source: Life Science. Unidade: FMRP

    Subjects: DIABETES MELLITUS, ENDOTÉLIO VASCULAR, MÚSCULO LISO VASCULAR, ENDOTELINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MATSUMOTO, Takayuki et al. Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system. Life Science, v. 118, n. 2, p. 129-135, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2013.12.216. Acesso em: 29 set. 2024.
    • APA

      Matsumoto, T., Lopes, R. A. M., Taguchi, K., Kobayashi, T., & Tostes, R. de C. A. (2014). Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system. Life Science, 118( 2), 129-135. doi:10.1016/j.lfs.2013.12.216
    • NLM

      Matsumoto T, Lopes RAM, Taguchi K, Kobayashi T, Tostes R de CA. Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system [Internet]. Life Science. 2014 ; 118( 2): 129-135.[citado 2024 set. 29 ] Available from: https://doi.org/10.1016/j.lfs.2013.12.216
    • Vancouver

      Matsumoto T, Lopes RAM, Taguchi K, Kobayashi T, Tostes R de CA. Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system [Internet]. Life Science. 2014 ; 118( 2): 129-135.[citado 2024 set. 29 ] Available from: https://doi.org/10.1016/j.lfs.2013.12.216

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024